United States · FDA National Drug Code directory
Metronidazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50111-333_dece18c5-c8f0-4f76-9809-c9fd9d1905c1
- Product NDC
- 50111-333
- Form
- TABLET
- Composition / generic term
- Metronidazole
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19900930
- Source listing expiry
- 20271231
Source-listed ingredients
- METRONIDAZOLE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (50111-333-01) · 50111-333-01
- 500 TABLET in 1 BOTTLE (50111-333-02) · 50111-333-02
- 250 TABLET in 1 BOTTLE (50111-333-06) · 50111-333-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →